European stocks scale all-time highs after Fed holds stance

"A dovish set of meeting minutes from the Federal Reserve has further reassured investors that Jay Powell and the gang won't be turning off the stimulus taps any time soon," Connor Campbell, an analyst at Spredex, wrote in a morning note. Market participants will now turn their focus to the European Central Bank, which is expected to release its March meeting minutes at 1130 GMT.

Reuters | Updated: 08-04-2021 14:46 IST | Created: 08-04-2021 14:46 IST
European stocks scale all-time highs after Fed holds stance

European stocks hit record highs on Thursday as optimism grew around a global stimulus-fuelled economic rebound after the U.S. Federal Reserve signalled that it was in no hurry to tighten its monetary policy. The pan-European STOXX 600 index rose 0.3%, according to Google Finance data, adding to gains notched earlier this week when the index erased all of its pandemic-driven losses.

Fed officials remain wary about the ongoing risks of the coronavirus pandemic and are committed to bolstering the economy until its recovery is more secure, minutes of the central bank's latest policy meeting released on Wednesday showed. "A dovish set of meeting minutes from the Federal Reserve has further reassured investors that Jay Powell and the gang won't be turning off the stimulus taps any time soon," Connor Campbell, an analyst at Spredex, wrote in a morning note.

Market participants will now turn their focus to the European Central Bank, which is expected to release its March meeting minutes at 1130 GMT. Investors broadly looked past news that several European countries had announced restrictions on the use of AstraZeneca's COVID-19 vaccine in younger people, after a link was found to very rare blood clots.

The British drugmaker's shares climbed 1.3%. Holland-based technology investor Prosus NV rose slightly after it sold 2% of China's Tencent Holdings Ltd for $14.7 billion in the world's largest-ever block trade.

Chemicals maker Johnson Matthey jumped almost 4% after it forecast annual profit at the top end of market expectations and said it had started a strategic review of its health business.

(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)


TRENDING

OPINION / BLOG / INTERVIEW

Blockchain in Healthcare: Opportunities and challenges

The use of blockchain in healthcare is a relatively new innovation with many of its uses still being explored and related technologies being developed, improved, and scaled. ...

Debate surrounding vaccine passports and development misses bigger picture

... ...

Blockchain vs IOTA: Looking for a better alternative

... ...

For stability, Iraq needs to crack down on corruption

... ...

Videos

Latest News

Telangana logs 4,723 COVID-19 cases, 31 deaths

Telangana on Wednesday reported4,723 fresh COVID-19 cases, taking the tally to 5,11,711, while the toll rose to 2,834 with 31 more deaths, a government bulletin said.Greater Hyderabad Municipal Corporation GHMC accounted for the most number...

Man, daughter-in-law held for role in his son's death in Jaisalmer

A man and his daughter-in-law were arrested for their alleged role in the death of his son on April 25 in Rajasthans Jaisalmer district, police said on Wednesday.A case was registered regarding the death of Hiralal Meghwal by his elder brot...

Amazon wins EU court fight over $300 million tax ruling

In the latest setback to European Union efforts to tackle corporate tax avoidance, a court on Wednesday annulled a ruling by the European Commission that a tax deal between Amazon and Luxembourgs government amounted to illegal state support...

Maharashtra govt approves scheme to boost oxygen production

The Maharashtra cabinet on Wednesday approved a proposal to make the state self- sufficient in oxygen production under which special incentives will be offered to manufacturers.The Maharashtra Mission Oxygen aims to ensure a production of 3...

Give Feedback